Imugene to open new PD1-Vaxx Phase 2 bowel cancer clinical t

Imugene Ltd (ASX:IMU, OTC:IUGNF) is preparing 10 clinical trial sites in Australia and the UK for a new PD1-Vaxx Phase 2 colorectal (CRC) cancer clinical...

Related Keywords

United Kingdom , Australia , Australian , Tony Dhillon , Leslie Chong , Intestinal Trials Group , University Of Southampton Clinical Trials Unit , Imugene Ltd , University Of Southampton , Vaxx Phase , Royal Surrey Hospital , Australasian Gastro Intestinal Trials Group , Tim Price , Southampton Clinical Trials Unit , Investigator Sponsored ,